Moderna Misses Sales Forecasts, But Maintains Full-Year Outlook
Moderna stock could take a hit Thursday after the biotech company reported light sales of its Covid vaccine and RSV vaccine. The post Moderna Misses Sales Forecasts, But Maintains Full-Year Outlook appeared first on Investor's Business Daily.
Moderna stock could take a hit Thursday after the biotech company reported light sales of its Covid vaccine and RSV vaccine.
The post Moderna Misses Sales Forecasts, But Maintains Full-Year Outlook appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
